Table 1.
Isolates | Date of isolation | Source | MLST | MIC (mg/L)
|
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IMP | MEM | CST | TGC | AK | LVX | CTX | FEP | FOS | ATa | CIa | CPSa | TSa | ||||
| ||||||||||||||||
E-FQ | March 8, 2017 | Human ascites | 2736 | 16 | 32 | 8 | 1 | 8 | 64 | >256 | 256 | 1,024 | 12 | >32 | >256 | >32 |
E-XS | March 8, 2017 | Human hydrothorax | 2736 | 16 | 32 | 8 | 1 | 8 | 64 | >256 | 256 | 1,024 | 12 | >32 | >256 | >32 |
E-DB | March 28, 2017 | Human feces | 2736 | 32 | 32 | 4 | 8 | 8 | 128 | >256 | >256 | 1,024 | 16 | >32 | >256 | >32 |
ATCC 25922 | Laboratory | 0.125 | <0.125 | 0.25 | 0.125 | 2 | <0.125 | 0.125 | <0.125 | 1 |
Notes:
MICs were interpreted by Etest by following the manufacturer’s instructions for CPS, CI, TS, and AT.
Abbreviations: MLST, multi-locus sequence typing; MIC/s, minimum inhibitory concentration/s; IMP, imipenem, MEM, meropenem, CST, colistin, TGC, tigecycline, AK, amikacin, LVX, levofloxacin, CTX, cefotaxime, FEP, cefepime, FOS, fosfomycin, AT, aztreonam, CI, ciprofloxacin, CPS, cefoperazone/sulbactam, TS, trimethoprim–sulfamethoxazole.